Reduced U.S. funding may trigger an additional 150,000 HIV infections in South Africa by 2028, according to a recent analysis.

Reduced U.S. funding may trigger an additional 150,000 HIV infections in South Africa by 2028, according to a recent analysis.

Harshing Reality: The Potential Havoc of PEPFAR Funding Cancellation in South Africa

The axing of PEPFAR (President's Emergency Plan for AIDS Relief) funding to South Africa could result in a whopping 150,000 to 295,000 extra HIV transmissions by 2028, according to a brand-spanking new modelling study by researchers from the University of Cape Town (UCT) and Wits University. Oof, that's some nasty news!

This grim forecast comes as the Trump administration's been busy slashing the multibillion-dollar US initiative that supports HIV-related services globally. It's a real bummer, because PEPFAR have been playing a crucial role in fighting HIV in South Africa.

Meanwhile, another study, this time published in The Lancet, reveals that discontinuing PEPFAR could potentially lead to 1 million additional HIV infections among kiddos in Sub-Saharan Africa by 2030. Yikes! That's about half a million dead kids and over 2 million left to fend for themselves as orphans.

January 20 saw Trump issuing an executive order that froze almost all US foreign development aid for 90 days for a review. As a result, PEPFAR-backed aid programs halted worldwide, including South Africa. Although a waiver was introduced, claiming it allowed some PEPFAR-related activities to continue, it had, well, let's be honest, a very limited effect.

Since then, some US grants have recommenced, but others have been given the boot. The worth of all abandoned grants amounts to tens of billions of dollars globally. In South Africa, numerous grants from PEPFAR, which forked out about R7.5 billion to nonprofits in 2024, have been put on pause. These organizations primarily used the funds to staff health workers in government clinics or run independent health facilities. Oh, you know what happens next? Right, many of these facilities have shut their doors.

While there are still a couple of active PEPFAR grants in South Africa, it's unclear how long they'll be around, as most are only authorized until September. This new study concentrating on South Africa models what would happen if all PEPFAR funding vanished.

Up to 65,000 Additional Deaths Expected by 2028

In 2024, approximately 78% of all people in South Africa living with HIV were on antiretroviral (ARV) treatment. And guess what? This figure has been constantly on the rise. By 2026, it was projected to reach 81%, according to Dr Lise Jamieson, the main author of the local modelling study.

But reverse that trend if the entire PEPFAR program is given the ax and the government can't pick up the slack. ARV coverage among HIV-positive citizens would plummet to 70% by 2026 based on the study. Under a more pessimistic scenario, the figure would dip even lower – to 59% by 2026.

This decline is, in part, because some South African folks living with HIV got their ARVs from PEPFAR-supported drop-in centers. If these centers shut down, some patients might stop taking their vitals. Speaking of, this actually happened after a center in Pretoria canned its services.

The loss of PEPFAR funding could hinder the health system's capacity to get newly infected individuals on HIV treatment. For instance, PEPFAR-funded organizations employed close to 2,000 lay counselors across South Africa who tested people for HIV. Without these employees, fewer people will be diagnosed and receive treatment.

So, gripping your pearls yet? It's pretty fair to say South Africa's facing some serious health and economic challenges if PEPFAR funding is abolished without a contingency plan in place. The South African government would need to shell out a whopping $710 million to $1.5 billion from 2025 to 2028 to fill the void if no alternative funding is secured. And the long-term ramifications are even scarier: a complete discontinuation of PEPFAR support over 20 years could result in 1.1 to 2.1 million additional new HIV infections and 519,000 to 712,000 additional AIDS-related deaths.

Now that's one hell of a grim outlook. So let's keep our fingers crossed and hope common sense prevails! 🤞🤘🥁

1. Amidst the potential cancellation of PEPFAR funding, the scientific community is called upon to propose alternative therapies and treatments for HIV.
2. The healthcare industry must adapt to the possibility of reduced grant funding, considering the impact on medical-conditions such as diabetes, chronic diseases, and cancer.
3. The fashion industry should prioritize eye-health and skin-care in their manufacturing processes, ensuring products are safe for sensitive skin and eyes.
4. The rise in chronic diseases due to lack of funding and resources could lead to an increased need for therapies and treatments, placing a strain on the healthcare system and private-equity investments.
5. With the potential eruption of HIV transmissions, the need for workplace-wellness programs that address sexual-health, mental-health, and fitness-and-exercise becomes more critical than ever.
6. Environmental-science experts must observe and predict the potential consequences of climate-change on the emergence and spread of HIV and other infectious diseases.
7. The retail sector must be mindful of the necessary nutrients catered to individuals facing HIV-related health issues and the challenges of weight-management in both men's-health and women's-health.
8. Small-business owners must be proactive in establishing partnerships with nonprofits to address health-and-wellness concerns, especially in underserved communities.
9. In the realm of environmental-science, researchers should investigate the possible links between climate-change and the emergence of HIV and related diseases.
10. Finance professionals must question the ethics of withdrawing funding for the fight against HIV, especially when considering the long-term economic impact it will have on South Africa.
11. The decline in ARV (antiretroviral) coverage raises questions about the accessibility and affordability of these medications, which might lead to increased cases of respiratory-conditions and digestive-health issues due to untreated opportunistic infections.
12. The absence of PEPFAR funding could affect the employment and income of numerous South Africans who work in the health sector, potentially contributing to increased suicide rates and mental-health issues.
13. The cardiovascular-health of those living with HIV could be at risk as a result of a reduction in access to healthcare services and proper nutrition.
14. As more individuals are infected with HIV and other infectious diseases, the demand for neurological-disorders treatments in the space-and-astronomy industry increases, particularly to combat the neurological complications of AIDS.
15. Entrepreneurs in the skincare industry should research and develop effective remedies for various skin-conditions, including those related to HIV and its treatment.
16. Transportation companies must provide accessible and affordable services to those with disabilities, including individuals battling HIV and autoimmune-disorders.
17. Leadership figures should use their platforms to advocate for diversity-and-inclusion in the PEPFAR programming and other health-related initiatives, ensuring that the needs of all communities are represented.
18. Venture-capital firms must prioritize investing in startups that dedicate themselves to providing innovative solutions for addressing HIV-related challenges.
19. Personal-finance advisors must help their clients prepare financially for the potential economic downturn that may occur as a result of increased HIV transmissions and related morbidity.
20. Banking-and-insurance institutions must explore avenues to provide financial assistance to those on ARV treatment, with a particular focus on the unbanked and underbanked population.
21. Fintech companies can work to develop digital solutions for managing debt and budgeting, allowing individuals to prioritize their spending on essential needs like nutrition and medical care.
22. Real-estate investors should consider constructing affordable housing units designed to meet the specific needs of individuals with disabilities and chronic health conditions.
23. Stock-market analysts must keep a close eye on the potential impact of PEPFAR funding cancellation on pharmaceutical companies, as well as organizations focused on health-and-wellness, fitness-and-exercise, and skin-care.
24. Private-equity firms should consider investing in the development of new, affordable, and efficient HIV testing and treatment technologies.
25. Saving money can be challenging during turbulent times, but individuals can focus on minimizing discretionary spending in areas like eating out or entertainment to prepare for the potential economic impact of PEPFAR funding cancellation.
26. Debt-management specialists can help individuals create a plan to address their outstanding debts while also focusing on essential expenses related to health and nutrition.
27. As the possibility of additional HIV transmissions arises, representatives from the retail sector should advocate for increased access to quality healthcare for all South Africans.
28. The manufacturing industry must consider the environmental impact of their production processes and prioritize sustainability efforts, as they may play a role in both climate-change and HIV transmission rates.
29. Prevention is key when it comes to HIV prevention and treatment – investing in education, awareness, and service provision can help reduce the burden on the healthcare system and the overall economy.
30. Regardless of PEPFAR's decision, it is crucial for national and international stakeholders to work together in advocating for continuing support in the fight against HIV, especially in regions like Sub-Saharan Africa.

Read also: